We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Since when was this the Provexis customer services board?
Whingeing for the sake of it, very bad manners, in a very superior way of course.
My monthly order is processed on the 24th of the month. I've been charged but no delivery and no response to a message on my account. Maybe the order should have been processed earlier to allow for the break. I can accept that it's possibly the RM but a lack of a response is just poor.
Interims on the wire again. LOL
The sp is showing 0.76p which is bellow the bid.
Don't think the mid has changed.
MMs drop SP prior to news tomorrow followed by 5% rise… MMs clean up…. Simples
News tmrw then
Thank you very much gixer ,I hope you are right
Nazir, you could also say. Why has it been positive for the past 3 years?
Last year temporary measures were introduced, due to Covid, to allow delayed publication of half-yearly reports and we were notified that they would be delayed till January 2021.
Hi Mickey my average is 5 p
What’s your average Naz?
gixer ,Why has this then been negative for the past month ,if there was so much potential, also last year they reported at the end of January, it's been 12 frustrating years ,we've been offered so much hope ,and every time we get optimistic are Hope's are dashed ,I want to get out ,but ,I just can't risk it.
Explanations of Dr. Zamanzadeh, Endocrinologist, Endocrinologist and Metabolist and Managing Director of East Tehran Diabetes Association @ dr.zamanzadeh Regarding the importance of preventing cardiovascular and cerebrovascular problems and its risk factors. The importance of consulting a doctor regularly. In individuals
https://www.instagram.com/p/CYDyP1ahUB_/
Not sure why you would want DSM or By-Health to buy us out before BH get Regulatory clearance in China for Fruitflow.
Blue Cap and a new permitted health function claim not to mention development and approval of Fruitflow as a drug would, IMO, add considerable value once achieved. I doubt I would accept any offer ATM.
As for any other questions, why not wait a couple of days till the interim results are released.
What's 2022 ,is going to bring for the shareholders ,same old same or the prospect of Byhealth or Dsm buying us out
As I have a few moments before the festivities take off I thought I would share this one.
"A human subject research: the effect of By-health Fruitflow tablets on platelet aggregation"
Date of Registration:2021-12-15
http://www.chictr.org.cn/showprojen.aspx?proj=129186
There has been human studies done on Fruitflow and platelet aggregation in China before so I am not sure of the exact differences on this one but it seems to be a Cohort study instead of a Parallel study and is to evaluate the effect of FF over 30-day period and possibly to measure different outcomes from the the previous studies.
Anyway, Have a great day all.
Among China's 1.4 billion population, estimated 200-300m diabetics, 500m suffer from cardio vascular related conditions, FF is a great product to alleviate the risks associated with the above mentioned chronicle conditions. With By-Health scientific and research director is the original FF technology developer coming out of Aberddeen university, and the Chinese government policy shift and By-Health huge research investment so far, FF China market sale revenue figure can be exponential . Judging recent posting indicated Amazon and H&B online stores ran out of FF, hope the half yearly revenue figure will be substancial.
Yep. I keep reading bits about Health China 2030 and then reading the By-Health claim “ Fruitflow that can demonstrate an anti-platelet effect, inhibiting platelet function and conferring beneficial effects for people who are at risk of platelet hyperactivity-associated thrombosis - the aberrant blood clots which lead to heart attacks and strokes”
I feel that the Chinese government are linked to this by the Healthy China 2030 initiative. I have looked lots and can’t put my finger on it, just feel they are close to this.
and this one is by Dr. Khosroshahi - Diabetologist - about the primary prevention of cardiovascular disease risks by lifestyle modification.
Pity they are not in English but you get the idea.
https://www.instagram.com/p/CXndLZYl-Tt/
Dr_Horrible, RE: I also think that FF could be recommended by the government for primary prevention of CVD, which would be amazing!
You might find this recent webinar from Vestolux interesting. Although I haven't downloaded the actual webinar (might not be in English) the powerpoint presentation is interesting.
Webinar Tachra Pharmed Company was held on December 17th with the presence of professors, Dr. Estefami, Dr. Nikoosakhen, Dr. Zamanzadeh, and Dr. Riahi.
This program was held in collaboration with Iranian Diabetes Association and Gabric Diabetes Association in order to raise attention to the primary causes of cardiovascular diseases.
You can view the offline video of the program by clicking on the link below
https://lnkd.in/dK6qfpYt
Username: vestolux
Password: vestolux
Vestolux have been pretty active with webinars etc and here is the most professional bodybuilder in Iran on the vestolux stand talking about ..... errr something :)
https://www.instagram.com/p/CXsqlSmoHoW/
Merry Christmas all fellow long term holders.Hopefully get some new information in the coming update.
Yes merry christmas to all genuine holders. Feel next year is the beginning of a huge re-rate
Thanks a lot for the responses.
By the looks of it, most have been holding off buying for quite a long while now, me too. the MM's have tried to make a market by moving it around on the low volume, but they've always left the Ask fairly high, discouraging buys. My thoughts only, but I have the impression that it wouldn't take much more buying and holding for movement to occur.
Merry Christmas all, Happy, healthy and prosperous 2022
Dr_H RE: Anything else?
Revenue from FF+O from the Chinese Distributor.
Info on By-Health development and approval of Fruitflow as a drug
Promotion of Fruitflow benefits against the effects of Covid-19 due to increased consumer interest in this area.
Alfista, that question maybe easier to answer after the interim results which should be released within the next 6 trading days but yes, as soon as revenue is flowing from By-Health, at least, then I foresee a share price far north of what it is at the moment.
IMO DYOR etc etc.
Also if the 8 studies carried out by By-Health are published, they will draw a lot of attention. This may lead to further evidence for the likes of NHS.
alf
for me it is a numbers game. Number of worldwide users x profit/dose. The potential is phenomenal if FF can get into the mainstream. I believe the price is being kept at current levels by current key investors as simply we want solid growth based on good financials so they can exit in a controlled manner at a good price - a repeat of 2009 is no good for anyone who has a notifiable interest.
Adding to Dr's comments, I would like to see FF prescribable by NHS.
W$
(I also believe in Santa!!)